Strategic Partnerships Curebase has a history of forming partnerships with healthcare and research organizations (Walgreens, Redenlab, BEKHealth) to expand reach and capabilities. Use this to position co-sell opportunities with EDC, eConsent, and decentralized trial tech to broaden distribution channels and accelerate customer onboarding.

Decentralized Trial Growth The company emphasizes decentralized and at-home trial capabilities, including a platform launched for at-home Covid-19 vaccine trials. Target sponsors and CROs pursuing patient-centric, geographically diverse enrollment and faster trial execution.

AI-native Platform Hope Voice AI Agent and a unified eClinical system across recruitment, data capture, ePRO, EDC, and compliance monitoring present a compelling value proposition for sponsors seeking higher data quality and streamlined operations at a lower cost.

Site-Tech Accessibility Sitebase offers free CTMS, eISF, and eSource to research sites, addressing financial barriers. This creates an entry point for upsell to full-suite enterprise features for sponsors who want centralized control and pristine data.

Financial Momentum With 40M funding and revenue in the mid-range tens of millions, Curebase shows growth readiness and investor backing, enabling scale-out of sales efforts targeting mid-market sponsors and mid-sized CROs seeking modern, patient-focused trial platforms.